Following the (mAb) leader: leveraging monoclonal antibody cell line development & banking CMC strategies for iPSC-derived cell therapies

Cell & Gene Therapy Insights 2024; 10(1), 29–33

DOI: 10.18609/cgti.2024.005

Published: 17 January
Viewpoint
Damien Fink



"For iPSC-derived cell therapies, the establishment of a master cell bank enables the application of GFI CMC and ICHQ5D principles.”